These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 10550415)

  • 1. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.
    Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O
    Diabetologia; 1999 Nov; 42(11):1314-23. PubMed ID: 10550415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
    Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB
    Eur J Endocrinol; 1996 Oct; 135(4):425-32. PubMed ID: 8921824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
    Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
    Toft-Nielsen MB; Damholt MB; Madsbad S; Hilsted LM; Hughes TE; Michelsen BK; Holst JJ
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3717-23. PubMed ID: 11502801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families.
    Humphriss DB; Stewart MW; Berrish TS; Barriocanal LA; Trajano LR; Ashworth LA; Brown MD; Miller M; Avery PJ; Alberti KG; Walker M
    Diabetologia; 1997 Oct; 40(10):1185-90. PubMed ID: 9349600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes.
    Vauhkonen IK; Niskanen LK; Mykkänen L; Haffner SM; Uusitupa MI; Laakso M
    Eur J Endocrinol; 2000 Aug; 143(2):251-60. PubMed ID: 10913945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
    Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes.
    Astiarraga B; Chueire VB; Souza AL; Pereira-Moreira R; Monte Alegre S; Natali A; Tura A; Mari A; Ferrannini E; Muscelli E
    Diabetologia; 2018 Aug; 61(8):1829-1837. PubMed ID: 29732475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
    Mari A; Gastaldelli A; Natali A; Ostergard T; Schmitz O; Ferrannini E
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E541-6. PubMed ID: 15522997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
    Sonne DP; Hare KJ; Martens P; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G413-9. PubMed ID: 23275610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
    Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
    Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
    Vahl T; D'Alessio D
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients.
    Dalgaard M; Thomsen C; Rasmussen BM; Holst JJ; Hermansen K
    Metabolism; 2004 Jan; 53(1):77-83. PubMed ID: 14681846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.